UMass Boston News

Professor Arjun Jayadev hails Indian Supreme Court rejection of patent protection for cancer drug

Harry Konstantinidis | April 22, 2013

Professor Arjun Jayadev

On April 1, the Indian Supreme Court denied a request for patent protection for Gleevec, the cancer drug developed by Swiss pharmaceutical Novartis. 

In a recent article published in "Project Syndicate", Associate Professor of Economics Arjun Jayadev and Joseph E. Stiglitz, Professor of Economics at Columbia University and Nobel laureate, hail this decision as a very significant development not only in the fight against cancer, but also as a step towards freeing up resources for investments in education and poverty reduction across the developing world.

You can read the full article here.

Comments (0)

Comment on this story

Share This Story

  • Google+
  • LinkedIn
  • 617.287.5300
  • 100 Morrissey Blvd.
  • Boston, MA 02125-3393

  • © Copyright 2015 UMass Boston